Mihaela Aldea

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Marcelo V. Negrão, Haniel A. Araújo, Giuseppe Lamberti et al. · Cancer Discovery · 2023 · 166 citations · Full text

Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells.

Ciprian Tomuleasa, Olga Şoriţău, Anamaria Orza et al. · PubMed · 2012 · 102 citations

Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression

Mihaela Aldea, Lizza Hendriks, Laura Mezquita et al. · Journal of Thoracic Oncology · 2019 · 80 citations · Full text

Neuro-oncology, Tumor Dna Analysis, Oncology +7

Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study

Arnaud Bayle, Laïla Belcaid, Mihaela Aldea et al. · Annals of Oncology · 2023 · 66 citations · Full text

Dna Sequencing, Oncology, Sequencing +13

Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells.

Mihaela Aldea, Bobe Petrushev, Olga Şoriţău et al. · PubMed · 2014 · 52 citations